✦ LIBER ✦

510 HBsAg levels under interferon and lamivudine therapy in HBeAg-negative chronic hepatitis B (CHBe-) patients

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Lamivudine therapy in HBeAg negative chr

✍ Guclu, E.; Batirel, A.; Ince, N. Koc; Ogutlu, A.; Durmaz, Y.; Ozdemir, D.; Geyik 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 64 KB

Changes of HBsAg and interferon-inducibl

✍ Papatheodoridis, George; Goulis, John; Manolakopoulos, Spilios; Margariti, Aikat 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 765 KB

Lamivudine/pegylated interferon alfa-2b

✍ Themistoklis Vassiliadis; Konstantinos Tziomalos; Kalliopi Patsiaoura; Thomas Za 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 88 KB

Durability of hbeag seroconversion in ch

✍ A.B. Van Nunen; B. Hansen; D. Suh; H. Loehr; H. Fontaine; L. Chemello; B. Song; 📂 Article 📅 2001 🏛 Elsevier Science 🌐 English ⚖ 132 KB

Commentary: HBsAg levels as predictor of

✍ S. J. Hadziyannis 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 57 KB

HBV DNA suppression and HBsAg clearance

✍ Massimo Fasano; Pietro Lampertico; Alfredo Marzano; Vito Di Marco; Grazia Anna N 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 541 KB